Damia, G <br/><br/>
Cisplatinum and taxol induce different patterns of p53 phosphorylation.  [electronic resource] 

 -  Neoplasia (New York, N.Y.)   
 - 10-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-8002 
<br/><br/><label>Standard No.: </label>10.1038/sj.neo.7900122  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androstadienes--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Ataxia Telangiectasia Mutated Proteins<br/>Blotting, Western<br/>Cell Cycle Proteins--metabolism<br/>Cisplatin--pharmacology<br/>Colonic Neoplasms--metabolism<br/>Cyclin-Dependent Kinase Inhibitor p21<br/>Cyclins--metabolism<br/>DNA-Activated Protein Kinase<br/>DNA-Binding Proteins<br/>Female<br/>Humans<br/>Mitogen-Activated Protein Kinases--metabolism<br/>Nuclear Proteins<br/>Ovarian Neoplasms--metabolism<br/>Paclitaxel--pharmacology<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Phosphorylation<br/>Protein Processing, Post-Translational<br/>Protein Serine-Threonine Kinases--metabolism<br/>Proto-Oncogene Proteins--metabolism<br/>Proto-Oncogene Proteins c-mdm2<br/>Transcription, Genetic<br/>Tumor Cells, Cultured--drug effects<br/>Tumor Suppressor Protein p53--metabolism<br/>Wortmannin